Key result
Higher mtDNA fraction with breaks linked to ~34% lower lung cancer odds in never-smoking women.
Why the study?
Previous studies on mtDNA copy number and lung cancer risk showed mixed findings, and the association of prediagnostic mtDNA fraction with breaks and copy number with lung cancer risk in never-smoking women remained unclarified.
Is prediagnostic mitochondrial DNA fraction with breaks associated with incident lung cancer risk in never-smoking women?
Is prediagnostic mitochondrial DNA fraction with breaks associated with incident lung cancer risk in never-smoking women?
Lower mitochondrial DNA fraction with breaks is associated with increased lung cancer risk among never-smoking women, particularly those with low mtDNA copy number.
Should not support routine mtDNA testing for risk assessment; hypothesis-generating for mitochondrial integrity in never-smoker lung cancer but needs prospective validation.
Introduction Lung cancer is the leading cause of cancer-related mortality worldwide, with approximately 25% of cases occurring in never-smokers, particularly East Asian women. Mitochondria are critical regulators of cellular energy production and oxidative stress responses, and mitochondrial DNA (mtDNA) is especially susceptible to damage from environmental exposures. While findings from previous studies on mtDNA copy number (mtDNAcn) and lung cancer risk have been mixed, mtDNA fraction with breaks (mtDNAfb) has recently emerged as a potential marker of oxidative stress and mitochondrial integrity. We investigated associations between prediagnostic mtDNAfb, mtDNAcn, and lung cancer risk in never-smoking women in the prospective Shanghai Women’s Health Study (SWHS). Methods This nested case-control study included 789 incident lung cancer cases and 789 controls individually matched on birth year and blood collection date from the SWHS, a prospective cohort of 74,942 women enrolled between 1996 and 2000. DNA was extracted from white blood cells or buccal cells, and mtDNAfb was quantified using a high-throughput qPCR assay comparing amplification signals from TaqI-treated (digested) and untreated samples. Relative mtDNAcn was derived from qPCR measurements normalized to a reference gene. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the associations of mtDNAfb and mtDNAcn with lung cancer risk, adjusting for age, body mass index, and assay plate. Sensitivity analyses further controlled for education, environmental tobacco smoke exposure, family history of lung cancer, and mutual adjustment for mtDNAfb and mtDNAcn. Interaction between mtDNAfb and mtDNAcn was tested on a multiplicative scale. Results We observed higher mtDNAfb was associated with lower risk of lung cancer with participants in the highest mtDNAfb tertile having 34% lower odds compared with those in the lowest tertile (p trend = 0.026). No independent association was observed for mtDNAcn; however, a multiplicative interaction between mtDNAfb and mtDNAcn was identified (p interaction = 8.3 × 10-6) where the association between mtDNAfb and lung cancer was more pronounced among participants with low mtDNAcn (OR = 0.47, 95% CI: 0.29-0.78) than those with high mtDNAcn (OR = 1.02, 95% CI: 0.58-1.79). Conclusions Lower mtDNAfb was associated with increased lung cancer risk among never-smoking women, particularly among women with low mtDNAcn, suggesting possible pathologic reductions in mitochondrial biogenesis and functioning, and consequently, reduced innate immune activation. These findings provide novel insights into mitochondrial dysfunction as a potential mechanism underlying lung cancer in never-smokers and warrant replication and mechanistic investigation in future studies. Citation Format: Batel Blechter, Xiao-Ou Shu, Wei Hu, Elizabeth Francies, Wei Zheng, Yu-Tang Gao, Qiuyin Cai, Hui Cai, Gong Yang, H. Dean Hosgood, Richard Cawthon, Qing Lan. Mitochondrial DNA breaks and copy number and the risk of lung cancer in never-smoking women [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3592.
No takes yet. Share an insight, caveat, or question.
Blechter et al. (2026) studied this question. Higher mitochondrial DNA fraction with breaks was associated with 34% lower odds of lung cancer in never-smoking women, especially among those with low mitochondrial DNA copy number.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: